Latest news with #Pataki
News18
21-05-2025
- Entertainment
- News18
Who Is Ranya Rao? What Is The Gold Smuggling Case Against The Kannada Actress?
Last Updated: Ranya Rao Gold Smuggling Case: The case against Ranya Rao came to light on March 3 when she was apprehended by DRI officials at Kempegowda International Airport in Bengaluru. Kannada actress Ranya Rao was thrust into the spotlight over her alleged involvement in a high-profile gold smuggling case that has seen her arrested and linked to a multi-crore illicit operation. The Enforcement Directorate (ED) today raided a medical college in Tumakuru linked to Karnataka Home Minister G. Parameshwara and the ongoing investigation into the Ranya Rao gold smuggling case. Who is Ranya Rao? Ranya Rao is an Indian actress and model primarily known for her work in Kannada cinema. She made her debut in the 2014 film Maanikya and has appeared in other Kannada films, including Pataki. Born on May 28, 1993, in Chikmagalur, Karnataka, she is also the stepdaughter of senior IPS officer K. Ramachandra Rao. What Is The Gold Smuggling Case In Which Ranya Rao Is Involved? The case against Ranya Rao came to light on March 3 when she was apprehended by Directorate of Revenue Intelligence (DRI) officials at Kempegowda International Airport in Bengaluru upon her arrival from Dubai. Authorities seized 14.2 kg of 24-karat gold bars, valued at over ₹12.56 crore, which were allegedly concealed on her body, including around her waist, calves and in her shoes and pockets. Subsequent investigations revealed a potentially larger and more complex smuggling network which included Ranya Rao's numerous trips to Dubai – 34 times between 2023 and 2025. Further investigations suggested that she may have smuggled a total of 49.6 kg of gold worth over ₹40 crore with the assistance of a jeweller, Sahil Sakariya Jain, who was also arrested. A subsequent raid on Ranya Rao's residence uncovered gold jewellery worth over ₹2 crore and cash amounting to ₹2.67 crore. Ranya Rao was initially remanded to judicial custody under the Customs Act. While a special court in Bengaluru granted her default bail on May 20 due to the DRI's failure to file a chargesheet within the stipulated 60 days, she remains in custody. The case is being jointly investigated by the Directorate of Revenue Intelligence (DRI), the Enforcement Directorate (ED), and the Central Bureau of Investigation (CBI. The Karnataka government has also formed a special team to probe any potential involvement of her stepfather, DGP Ramachandra Rao, although he has publicly distanced himself from the controversy. Ranya Rao, along with co-accused Tarun Raju and Sahil Sakariya Jain, is currently lodged at the Bengaluru Central Prison. First Published: May 21, 2025, 12:01 IST
Business Insider
12-05-2025
- Business
- Business Insider
Analysts Have Conflicting Sentiments on These Healthcare Companies: Entrada Therapeutics Inc (TRDA) and Qiagen (QGEN)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Entrada Therapeutics Inc (TRDA – Research Report) and Qiagen (QGEN – Research Report). Protect Your Portfolio Against Market Uncertainty Entrada Therapeutics Inc (TRDA) Roth MKM analyst Boobalan Pachaiyappan maintained a Buy rating on Entrada Therapeutics Inc yesterday and set a price target of $21.00. The company's shares closed last Friday at $8.38. According to Pachaiyappan is a 1-star analyst with an average return of -6.3% and a 34.3% success rate. Pachaiyappan covers the Healthcare sector, focusing on stocks such as Reviva Pharmaceuticals Holdings, Gain Therapeutics, and Verona Pharma. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Entrada Therapeutics Inc with a $24.33 average price target, a 180.6% upside from current levels. In a report issued on May 8, TD Cowen also maintained a Buy rating on the stock. Qiagen (QGEN) In a report issued on May 8, Maja Pataki from Kepler Capital maintained a Hold rating on Qiagen, with a price target of EUR42.17. The company's shares closed last Friday at $41.86. According to Pataki has 0 stars on 0-5 stars ranking scale with an average return of -13.7% and a 33.8% success rate. Pataki covers the Healthcare sector, focusing on stocks such as Tecan Group AG, Demant, and Alcon. Qiagen has an analyst consensus of Moderate Buy, with a price target consensus of $49.29, representing a 14.5% upside. In a report issued on April 24, UBS also maintained a Hold rating on the stock.
Business Insider
11-05-2025
- Business
- Business Insider
Kepler Capital Sticks to Their Hold Rating for Coloplast A/S (0QBO)
Kepler Capital analyst Maja Pataki maintained a Hold rating on Coloplast A/S (0QBO – Research Report) on May 9 and set a price target of DKK715.00. The company's shares closed last Friday at DKK643.92. Protect Your Portfolio Against Market Uncertainty Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox. Pataki covers the Healthcare sector, focusing on stocks such as Tecan Group AG, Alcon, and Demant. According to TipRanks, Pataki has an average return of -13.7% and a 33.76% success rate on recommended stocks. In addition to Kepler Capital , Coloplast A/S also received a Hold from RBC Capital's Jack Reynolds-Clark in a report issued on May 9. However, on May 7, Morgan Stanley maintained a Sell rating on Coloplast A/S (LSE: 0QBO).
Business Insider
04-05-2025
- Business
- Business Insider
Kepler Capital Remains a Hold on Coloplast A/S (0QBO)
In a report released on May 2, Maja Pataki from Kepler Capital maintained a Hold rating on Coloplast A/S (0QBO – Research Report), with a price target of DKK870.00. The company's shares closed last Friday at DKK699.84. Protect Your Portfolio Against Market Uncertainty Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox. According to TipRanks, Pataki is an analyst with an average return of -14.0% and a 32.77% success rate. Pataki covers the Healthcare sector, focusing on stocks such as Tecan Group AG, Alcon, and Demant. Coloplast A/S has an analyst consensus of Hold, with a price target consensus of DKK849.00.
Yahoo
24-02-2025
- Business
- Yahoo
George Pataki praises Trump for killing congestion pricing — and calls for an NY version of DOGE
Former Gov. George Pataki praised President Trump for moving to kill congestion pricing — and said New York needs its own cost-slashing version of DOGE. Pataki, a Republican, said Gov. Kathy Hochul 'wanted the money' from the $9 toll to enter Manhattan to fund the cash-strapped Metropolitan Transportation Authority. 'New York State gets enough money — too much money — from the taxpayers,' Pataki said on WABC 770s AM's 'The Cats Roundtable.' 'They don't need more,' Pataki said. 'New York is too expensive. The government costs too much. We could use a little DOGE [Department of Government Efficiency] in Albany and City Hall instead of raising taxes.' He noted that the MTA is asking for billions more in capital funding from Albany — well beyond the revenues generated from the congestion toll. 'It never ends,' Pataki said of the proposed $65 billion, five-year plan. 'It's unsustainable.' The MTA has sued to block the Trump administration from rescinding the toll and congestion pricing remains in effect for the time being. Although New York's last Republican governor had praise for Trump, he said he was baffled by the commander-in-chief's handling of the negotiations to end Russia's brutal war against Ukraine. Pataki said Trump appeared to be harder on Ukraine and President Volodymyr Zelensky than on Russia and its leader Vladimir Putin, who invaded Ukraine three years ago, on Feb. 24, 2022. Pataki has visited Ukraine numerous times as part of relief efforts through his charitable group. 'President Trump's positioning on Ukraine so far has been completely wrong,' Pataki told host John Catsimatidis. He likened it to how former President Joe Biden handled the Hamas-Israel conflict, putting too much pressure on Israel instead of Hamas. 'Sadly, I think, Trump is making the same mistake that Biden made with Israel in the case of Ukraine,' the former three-term governor said. 'Instead of putting all the pressure on Putin — who's clearly the bad guy, a horrible human being — he's putting the pressure on Ukraine. 'I don't think anyone wants the war to end sooner than the Ukrainian people,' he went on. 'But the way to do it is not to pressure Ukraine. It's to pressure Putin and Russia, because they're the ones that are wrong. They're the ones who have acted like barbarians … And they're the ones who should be under the pressure to reach a reasonable peace.' Pataki called Putin a 'killer who is anti-American, anti-Western, anti-civilization.' The Post reached out to the White House for comment. Washington and Kyiv engaged in a tense exchange of barbs over the past week. Trump, who is trying to bring the fighting to a close on terms that Kyiv at one point said were too favorable to Moscow, lashed out at Zelensky, writing on Truth Social on Feb. 19 that the Ukrainian leader was a 'dictator without elections.' 'In the meantime, we are successfully negotiating an end to the War with Russia, something all admit only 'TRUMP,' and the Trump Administration, can do,' he wrote in a lengthy Truth Social rant, referencing Ukraine suspending elections last year due to the war — as dictated in Ukrainian law. 'Biden never tried, Europe has failed to bring Peace, and Zelenskyy probably wants to keep the 'gravy train' going. I love Ukraine, but Zelenskyy has done a terrible job, his Country is shattered, and MILLIONS have unnecessarily died – And so it continues.' The Post reported Friday that tensions cooled between Washington and Kiev. The Trump administration is said to be close to a deal with Ukraine for access to hundreds of billions of dollars worth of mineral rights in a giant step toward ending Russia's grinding war on the European nation.
